TABLE 3.

LAN TEAE profile (intensity, causality)

TEAE	Total (n = 50)
Any TEAE	50 (100) [509]
Intensity of TEAEs
Mild	47 (94.0) [297]
Moderate	39 (78.0) [171]
Severe	19 (38.0) [41]
Causality of TEAEs
Related	23 (46.0) [52]
Not related	50 (100) [456]
Missing	1 (2.0) [1]
Intensity and causality of TEAEs
Mild and related	20 (40.0) [33]
Moderate and related	8 (16.0) [14]
Severe and related	3 (6.0) [5]
Missing and related	0
TEAEs leading to treatment discontinuation	5 (10.0) [8]
TEAEs leading to study withdrawal	4 (8.0) [4]
TEAEs leading to death	3 (6.0) a [3]
Serious TEAEs	12 (24.0) [34]

Data are presented as number of patients (percentage of patient) [number of events]. Patients with several AEs of different intensities or causalities are counted once for each intensity/causality concerned.

LAN, lanreotide autogel; TEAE, treatment‐emergent adverse event.

^a None were related to treatment.